{"prompt": "['Trial ID: LP0162-1325', 'Date: 14-Aug-2018', 'Version: 4.0', 'Page 169 of 169', 'Section number and', 'Description of change', 'Brief rationale', 'name', 'Appendix 9', 'New appendix', 'Guidance for the investigators', 'WHO model', 'regarding the classification of', 'prescribing', 'topical corticosteroids as well as', 'information for', 'examples have been added to the', 'classification of', 'protocol. In Section 9.7 (Rescue', 'topical', 'treatment), a cross reference to', 'corticosteroids', 'Appendix 9 has also been added.', 'Throughout', 'Minor editorial and document', 'Minor, have therefore not been', 'formatting revisions', 'summarised.', 'eDoc-00631888 - Version 4.0']['Signature Page for eDoc-00631888 v4.0', 'Reason for signing: Approved', 'Manage', 'ver Verdict(s)', 'Name: PPD', 'Capacit', 'Date of signature: 16-Aug-2018 17:22:10', 'GMT+0000', 'Reason for signing: Approved', 'Manage', 'Verdict(s)', 'Name: PPD', 'Capacil', 'Date of signature: 17-Aug-2018 06:55:39', 'GMT+0000', 'Reason for signing: Approved', 'Manage', 's)', 'Name: PPD', 'Capacil', 'Date of signature: 17-Aug-2018 10:01:46', 'GMT+0000', 'Electronic signatures made within eTMF LEO are considered to be a', 'legally binding equivalent of traditional handwritten signatures.', 'eDoc-00631888 - Version 4.0']\n\n###\n\n", "completion": "END"}